Plain-English translation of NCT05956587 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This is a Phase II trial testing two experimental medications called and in patients with advanced or spreading cancers, including lung cancer and nasopharyngeal cancer. Researchers want to see if giving these medications together is more effective than giving one alone, and to understand the right dose and schedule. The study will help determine whether this combination is safe and actually helps patients.
Current treatments for advanced lung cancer and nasopharyngeal cancer don't work for all patients, and some stop working over time. This trial is testing whether this new medication combination might offer another option for people whose cancers are advanced or have spread to other parts of the body.
You likely qualify if…
You likely don't qualify if…
You would receive the study medications in 3-week cycles. In the first cycle, you'll try the medication combination to see how your body responds. If the treatment helps and you tolerate it well, you can continue with additional cycles. Throughout the study, you'll have regular visits for blood tests, imaging scans, and check-ups to monitor how the cancer responds and watch for any side effects. Treatment will stop if your cancer progresses, side effects become too serious, or for other medical reasons.
AI-generated summary from trial data · Aug 5, 2026 · Not medical advice
China